导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.86% | 1805/4773 |
| 近一周 | -0.65% | 226/5462 |
| 近一月 | 3.60% | 130/5421 |
| 近一季 | 2.92% | 412/5209 |
| 近半年 | -0.53% | 1323/4920 |
| 近一年 | 1.86% | 2251/4366 |
| 近两年 | 24.37% | 2531/2954 |
| 近三年 | 23.75% | 1332/2253 |
| 成立以来 | 103.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.72% 1200/4961 |
-10.02% 4027/5312 |
- - |
- - |
| 2025 | 4.20% 3060/4813 |
-0.72% 2376/3635 |
5.94% 517/4076 |
-3.83% 4010/4524 |
3.01% 785/4813 |
| 2024 | 21.05% 424/3463 |
10.31% 69/2808 |
3.83% 246/3014 |
6.12% 2870/3129 |
-0.41% 1413/3463 |
| 2023 | 10.70% 87/2656 |
8.08% 498/2280 |
2.12% 164/2385 |
4.16% 157/2515 |
-3.71% 769/2655 |
| 2022 | 2.72% 24/2207 |
5.31% 35/1919 |
1.11% 1499/2016 |
-1.23% 18/2113 |
-2.32% 1795/2208 |
| 2021 | 18.10% 216/1822 |
6.45% 92/1255 |
5.06% 824/1330 |
9.84% 129/1466 |
-3.87% 1463/1822 |
| 2020 | 9.14% 847/1250 |
-11.28% 831/1028 |
6.52% 861/1067 |
11.84% 424/1164 |
3.26% 928/1184 |
| 2019 | - - |
- - |
- - |
- - |
8.17% 342/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华泰柏瑞中证红利低波ETF联接A VS. 长安沪深300非周期A(740101) |